<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0053">
 <label>53</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Matsumoto</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Miyamoto</surname>
    <given-names>N</given-names>
   </name>, 
   <name name-style="western">
    <surname>Hirayama</surname>
    <given-names>T</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors</article-title>. 
  <source>Bioorg Med Chem</source>
  <year>2013</year>;
  <volume>21</volume>:
  <fpage>7686</fpage>–
  <lpage>98</lpage>.
  <pub-id pub-id-type="pmid">24216091</pub-id>
 </mixed-citation>
</ref>
